CLX Q1 Deep Dive: Margin Gains Offset by Cautious Outlook and Guidance Reduction

Consumer products giant Clorox (NYSE:CLX) met Wall Street’s revenue expectations in Q1 CY2026, but sales were flat year on year at $1.67 billion. Its non-GAAP profit of $1.64 per share was 6.1% above analysts’ consensus estimates.